Parallax Volatility Advisers’s Envoy Medical Warrant COCHW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-20,000
Closed -$1.78K 2215
2023
Q3
$1.78K Buy
+20,000
New +$1.22K ﹤0.01% 2190
2023
Q2
Sell
-132,494
Closed -$4.66K 2457
2023
Q1
$4.66K Buy
132,494
+31,258
+31% +$1.76K ﹤0.01% 2486
2022
Q4
$3.85K Buy
101,236
+350
+0.3% +$17 ﹤0.01% 2658
2022
Q3
$7K Sell
100,886
-92,754
-48% -$8.39K ﹤0.01% 2851
2022
Q2
$21K Buy
193,640
+170,365
+732% +$36.5K ﹤0.01% 2584
2022
Q1
$6K Buy
+23,275
New +$10K ﹤0.01% 2701

Other funds holding COCHW

Parallax Volatility Advisers's COCHW Position: Q4 2023 in Review

Parallax Volatility Advisers sold out of Envoy Medical Warrant (COCHW) in Q4 2023, closing a stake of 20,000 shares — an estimated $1.78K sold.

Parallax Volatility Advisers first reported a position in COCHW in Q1 2022 and held it in 6 quarters. The position peaked at $21K in Q2 2022. 54 funds tracked by Wall St. Rank hold COCHW as of Q4 2023.

  • Parallax Volatility Advisers reported no remaining Envoy Medical Warrant position as of Q4 2023 after selling out during the quarter.
  • Parallax Volatility Advisers sold 20,000 Envoy Medical Warrant shares in Q4 2023, an estimated $1.78K.
  • Parallax Volatility Advisers first reported a position in Envoy Medical Warrant in Q1 2022 and held it in 6 quarters.
  • Parallax Volatility Advisers's Envoy Medical Warrant position peaked at $21K in Q2 2022.
  • 54 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q4 2023.

Based on Parallax Volatility Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.